Munafa Stock Market Course + Intraday & FNO calls 
Cellectar Biosciences (CLRB) Technical (Analysis) Reports Cellectar Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Cellectar Biosciences (CLRB)
Technical Analysis Report for NASDAQ stock CLRB Cellectar Biosciences. Dated: 24 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CLRB Cellectar Biosciences then click here. or read Experts views on Cellectar Biosciences or Forecast & share price targets of Cellectar Biosciences
Cellectar Biosciences Opened at 3.27 and Closed at: 3.01, which is -3.65% of previous session's close. It moved within a range of 3.00 and 3.27
The session was a Bearish session with an average volume of 14200, which is -61.27% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 2 days back on short term averages
Support for tomorrow is 2.87 and resistance for tomorrow is 3.14
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.92, 2.82 resistance for tomorrow's hourly charts is 3.19, 3.36
10 Day SMA for Cellectar Biosciences (CLRB) is 3.15 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Cellectar Biosciences (CLRB) is 3.1 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Cellectar Biosciences (CLRB) is 3.27 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 3.25 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Cellectar Biosciences is 3.9 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Cellectar Biosciences is at 3.1 and 200 DMA is at 3.9, while 50 DMA and 100 DMA are at 3.27 and 3.25 respectively
Cellectar Biosciences (CLRB) moving average of 20 SMA is at 3.1 and 20 EMA is at 3.14
| Date | Closing Price | 20 SMA | 20 EMA |
| 24 Tue Mar | 3.01 | 3.1 | 3.14 |
| 23 Mon Mar | 3.12 | 3.11 | 3.15 |
| 20 Fri Mar | 3.22 | 3.12 | 3.15 |
| 19 Thu Mar | 3.09 | 3.13 | 3.14 |
| 17 Tue Mar | 3.30 | 3.13 | 3.14 |
| 16 Mon Mar | 3.27 | 3.12 | 3.12 |
Cellectar Biosciences (CLRB) moving average of 50 SMA is at 3.27 and 50 EMA is at 3.21
| Date | Closing Price | 50 SMA | 50 EMA |
| 24 Tue Mar | 3.01 | 3.27 | 3.21 |
| 23 Mon Mar | 3.12 | 3.27 | 3.22 |
| 20 Fri Mar | 3.22 | 3.27 | 3.22 |
| 19 Thu Mar | 3.09 | 3.27 | 3.22 |
| 17 Tue Mar | 3.30 | 3.28 | 3.23 |
| 16 Mon Mar | 3.27 | 3.28 | 3.23 |
Cellectar Biosciences (CLRB) moving average of 100 SMA is at 3.25 and 100 EMA is at 3.36
| Date | Closing Price | 100 SMA | 100 EMA |
| 24 Tue Mar | 3.01 | 3.25 | 3.36 |
| 23 Mon Mar | 3.12 | 3.26 | 3.37 |
| 20 Fri Mar | 3.22 | 3.26 | 3.37 |
| 19 Thu Mar | 3.09 | 3.27 | 3.37 |
| 17 Tue Mar | 3.30 | 3.28 | 3.38 |
| 16 Mon Mar | 3.27 | 3.28 | 3.38 |
Cellectar Biosciences (CLRB) moving average of 200 SMA is at 3.9 and 200 EMA is at 3.26
| Date | Closing Price | 200 SMA | 200 EMA |
| 24 Tue Mar | 3.01 | 3.9 | 3.26 |
| 23 Mon Mar | 3.12 | 3.89 | 3.26 |
| 20 Fri Mar | 3.22 | 3.88 | 3.26 |
| 19 Thu Mar | 3.09 | 3.86 | 3.26 |
| 17 Tue Mar | 3.30 | 3.85 | 3.26 |
| 16 Mon Mar | 3.27 | 3.83 | 3.26 |
Cellectar Biosciences has performed better than 111 Inc in short term. Holding Cellectar Biosciences could be a better choice for now!
Kezar Life has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Kezar Life, about 4.96% more returns!
Cellectar Biosciences has performed better than Akari Therapeutics in short term. Holding Cellectar Biosciences could be a better choice for now!
Cellectar Biosciences has performed better than Lipocine Inc in short term. Holding Cellectar Biosciences could be a better choice for now!
Anavex Life has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Anavex Life, about 6.52% more returns!
Endra Life has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Endra Life, about 0.06% more returns!
Cellectar Biosciences has performed better than Neogen Corporation in short term. Holding Cellectar Biosciences could be a better choice for now!
Novocure has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Novocure, about 7.18% more returns!
Cellectar Biosciences has performed better than Cerus Corporation in short term. Holding Cellectar Biosciences could be a better choice for now!
Compugen has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Compugen, about 27.37% more returns!
Coherus Biosciences has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Coherus Biosciences, about 12.82% more returns!
Insulet Corporation has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Insulet Corporation, about 2.37% more returns!
Ensign Group has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Ensign Group, about 5.96% more returns!
Soligenix Inc has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Soligenix Inc, about 12.16% more returns!
Cellectar Biosciences has performed better than Theravance Biopharma in short term. Holding Cellectar Biosciences could be a better choice for now!
Cellectar Biosciences has performed better than Genprex Inc in short term. Holding Cellectar Biosciences could be a better choice for now!
Cellectar Biosciences has performed better than Inmune Bio in short term. Holding Cellectar Biosciences could be a better choice for now!
Voyager Therapeutics has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 14.12% more returns!
Xoma Corporation has performed better than Cellectar Biosciences in short term. You could have earned much better returns by investing in Xoma Corporation, about 18.48% more returns!
Cellectar Biosciences Technical analysis of indicators
Price action analysis of Cellectar Biosciences (CLRB) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cellectar Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Cellectar Biosciences in short term but the buy signal is initial and weak.
Cellectar Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Cellectar Biosciences in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Cellectar Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.13 and Cellectar Biosciences CLRB stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Cellectar Biosciences CLRB stock. Volume based technical analysis of Cellectar Biosciences CLRB stock is negative.
Cellectar Biosciences Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CLRB Cellectar Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CLRB Experts View which covers a lot of information including buying and selling signals
CLRB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cellectar Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Cellectar Biosciences (CLRB) Technical (Analysis) Reports Cellectar Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
